18th of November 2014: Defymed, was rewarded for the “Deloitte In Extenso Technology Fast 50” 2014 Price, in the category “Biotech of the Future”, for the best Fund raising in East of France for the year 2013: 1.2 M€. Under the theme ” Powerful connections” , the 14th edition of the Deloitte Technology Fast 50 In Extenso
Read full post »
Defymed will give an oral presentation at the 5th EPITA Winter Symposium & 34th AIDPIT Workshop on tuesday 27th of January 2015, session 6. Our oral presentation is entitled: “Preclinical validation of the MAILPAN®, a Bioartificial Pancreas to treat Type 1 Diabetes”. Looking forward to seeing you in Innsbruck! Fore more info: http://www.esot.org/events-education/past-events/1776/overview
28th of November 2014: The quality management system of Defymed has been approved to the following quality management standards: ISO 9001:2008 and ISO 13485:2003. The quality management system is applicable to: Research, Development and Manufacturing of implantable bio-artificial medical devices for diverse therapeutic applications. This approval is a great recognition to the efforts of Defymed to deliver high
Read full post »
